UK markets closed

EVAX Jul 2024 2.500 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.95000.0000 (0.00%)
At close: 10:31AM EDT
Full screen
Previous close1.9500
Open1.9500
Bid1.5000
Ask2.0000
Strike2.50
Expiry date2024-07-19
Day's range1.9500 - 1.9500
Contract rangeN/A
Volume1
Open interest8
  • GlobeNewswire

    Evaxion Announces Business Update and First Quarter 2024 Financial Results

    COPENHAGEN, Denmark, May 28, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion" or the "Company"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business update and announces first quarter 2024 financial results. Business Highlights Since Last Quarterly UpdateSince the 2023 full year financial results were released, the Company has continued to make progress on its three-pronged business model focusing on Targets, Pipeli

  • Globe Newswire

    Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024

    EVX-01 induced positive clinically relevant immune responses in all assessed patientsBooster immunizations tended to increase the immune responseThe observed immune responses were mediated by both CD4+ and CD8+ T-cells COPENHAGEN, Denmark, May 23, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announces its participation in the American Society of Clinical

  • GlobeNewswire

    Evaxion Receives Nasdaq Notification

    COPENHAGEN, Denmark, May 10, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced that on May 7, 2024, it received a letter (the “Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) Listing Qualifications Department notifying the Company that it is not currently in compliance with the minimum stockholders’ equity requirement. Nasdaq Listing Rule 5550(